INITIATOR PHARMA: Q1 2022 REPORT
Business highlights in Q1 2022 On January 20th the initiation of dosing in the IPTN2021 program Phase 1 to assess pain reducing effects in healthy volunteers was announced. On March 22nd it was…
All categories
English
Annual report 2021 for Initiator Pharma A/S
Initiator Pharma’s annual report for 2021 is now available on the company´s home page